533 related articles for article (PubMed ID: 26822324)
1. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.
Mita T; Katakami N; Shiraiwa T; Yoshii H; Onuma T; Kuribayashi N; Osonoi T; Kaneto H; Kosugi K; Umayahara Y; Yamamoto T; Matsumoto K; Yokoyama H; Tsugawa M; Gosho M; Shimomura I; Watada H;
Diabetes Care; 2016 Mar; 39(3):455-64. PubMed ID: 26822324
[TBL] [Abstract][Full Text] [Related]
2. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).
Mita T; Katakami N; Yoshii H; Onuma T; Kaneto H; Osonoi T; Shiraiwa T; Kosugi K; Umayahara Y; Yamamoto T; Yokoyama H; Kuribayashi N; Jinnouchi H; Gosho M; Shimomura I; Watada H;
Diabetes Care; 2016 Jan; 39(1):139-48. PubMed ID: 26628419
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.
Oyama J; Murohara T; Kitakaze M; Ishizu T; Sato Y; Kitagawa K; Kamiya H; Ajioka M; Ishihara M; Dai K; Nanasato M; Sata M; Maemura K; Tomiyama H; Higashi Y; Kaku K; Yamada H; Matsuhisa M; Yamashita K; Bando YK; Kashihara N; Ueda S; Inoue T; Tanaka A; Node K;
PLoS Med; 2016 Jun; 13(6):e1002051. PubMed ID: 27351380
[TBL] [Abstract][Full Text] [Related]
4. Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE).
Katakami N; Mita T; Irie Y; Takahara M; Matsuoka TA; Gosho M; Watada H; Shimomura I;
Cardiovasc Diabetol; 2018 Feb; 17(1):24. PubMed ID: 29402270
[TBL] [Abstract][Full Text] [Related]
5. Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study.
Tanaka A; Yoshida H; Nanasato M; Oyama JI; Ishizu T; Ajioka M; Ishiki R; Saito M; Shibata Y; Kaku K; Maemura K; Higashi Y; Inoue T; Murohara T; Node K
Int J Cardiol; 2018 Nov; 271():331-335. PubMed ID: 29803341
[TBL] [Abstract][Full Text] [Related]
6. Impact of sitagliptin on carotid intima-media thickness in patients with coronary artery disease and impaired glucose tolerance or mild diabetes mellitus.
Ishikawa S; Shimano M; Watarai M; Koyasu M; Uchikawa T; Ishii H; Inden Y; Takemoto K; Murohara T
Am J Cardiol; 2014 Aug; 114(3):384-8. PubMed ID: 24929624
[TBL] [Abstract][Full Text] [Related]
7. Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus.
Mita T; Katakami N; Shiraiwa T; Yoshii H; Kuribayashi N; Osonoi T; Kaneto H; Kosugi K; Umayahara Y; Gosho M; Shimomura I; Watada H
Sci Rep; 2017 Jan; 7():39965. PubMed ID: 28067320
[TBL] [Abstract][Full Text] [Related]
8. Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
Katakami N; Mita T; Yoshii H; Shiraiwa T; Yasuda T; Okada Y; Torimoto K; Umayahara Y; Kaneto H; Osonoi T; Yamamoto T; Kuribayashi N; Maeda K; Yokoyama H; Kosugi K; Ohtoshi K; Hayashi I; Sumitani S; Tsugawa M; Ryomoto K; Taki H; Nakamura T; Kawashima S; Sato Y; Watada H; Shimomura I;
Cardiovasc Diabetol; 2020 Jul; 19(1):110. PubMed ID: 32646498
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of concomitant antidiabetic agents on carotid atherosclerosis: a subgroup analysis of the PROLOGUE study.
Tanaka A; Kawaguchi A; Oyama JI; Ishizu T; Ito H; Fukui J; Kondo T; Kuroki S; Nanasato M; Higashi Y; Kaku K; Inoue T; Murohara T; Node K
Heart Vessels; 2019 Feb; 34(2):375-384. PubMed ID: 30284018
[TBL] [Abstract][Full Text] [Related]
10. Changes in carotid intima-media thickening in patients with type 2 diabetes mellitus: Subanalysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation.
Mita T; Katakami N; Shiraiwa T; Yoshii H; Gosho M; Shimomura I; Watada H;
J Diabetes Investig; 2017 Mar; 8(2):254-255. PubMed ID: 28256102
[TBL] [Abstract][Full Text] [Related]
11. Sex-Related Differences in Sitagliptin Treatment in Type 2 Diabetes: Results from the PROLOGUE Trial.
Wu X; Zhang S; Jin Y; Xiao X
Med Sci Monit; 2022 Nov; 28():e938030. PubMed ID: 36444134
[TBL] [Abstract][Full Text] [Related]
12. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease.
Koyasu M; Ishii H; Watarai M; Takemoto K; Inden Y; Takeshita K; Amano T; Yoshikawa D; Matsubara T; Murohara T
Clin Ther; 2010 Aug; 32(9):1610-7. PubMed ID: 20974318
[TBL] [Abstract][Full Text] [Related]
13. Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE).
Mita T; Katakami N; Shiraiwa T; Yoshii H; Onuma T; Kuribayashi N; Osonoi T; Kaneto H; Kosugi K; Umayahara Y; Yamamoto T; Matsumoto K; Yokoyama H; Tsugawa M; Gosho M; Shimomura I; Watada H
Diabetol Metab Syndr; 2014 Mar; 6(1):35. PubMed ID: 24607023
[TBL] [Abstract][Full Text] [Related]
14. Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy.
Irace C; Casciaro F; Scavelli FB; Oliverio R; Cutruzzolà A; Cortese C; Gnasso A
Cardiovasc Diabetol; 2018 Apr; 17(1):52. PubMed ID: 29631585
[TBL] [Abstract][Full Text] [Related]
15. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.
Hanefeld M; Chiasson JL; Koehler C; Henkel E; Schaper F; Temelkova-Kurktschiev T
Stroke; 2004 May; 35(5):1073-8. PubMed ID: 15073402
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation.
Mita T; Katakami N; Shiraiwa T; Yoshii H; Gosho M; Shimomura I; Watada H
Int J Endocrinol; 2017; 2017():1925305. PubMed ID: 28250768
[No Abstract] [Full Text] [Related]
17. Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.
Barbieri M; Rizzo MR; Marfella R; Boccardi V; Esposito A; Pansini A; Paolisso G
Atherosclerosis; 2013 Apr; 227(2):349-54. PubMed ID: 23375680
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibitor sitagliptin improves pancreatic β-cell function in hypertensive diabetic patients treated with angiotensin receptor blockers.
Fukui K; Kawahito H; Wakana N; Kikai M; Terada K; Yamamoto K; Irie D; Kato T; Miyagawa S; Yamada H
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1001-9. PubMed ID: 26195265
[TBL] [Abstract][Full Text] [Related]
19. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness.
Zanchetti A; Rosei EA; Dal Palù C; Leonetti G; Magnani B; Pessina A
J Hypertens; 1998 Nov; 16(11):1667-76. PubMed ID: 9856368
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.
Tanaka A; Murohara T; Taguchi I; Eguchi K; Suzuki M; Kitakaze M; Sato Y; Ishizu T; Higashi Y; Yamada H; Nanasato M; Shimabukuro M; Teragawa H; Ueda S; Kodera S; Matsuhisa M; Kadokami T; Kario K; Nishio Y; Inoue T; Maemura K; Oyama J; Ohishi M; Sata M; Tomiyama H; Node K;
Cardiovasc Diabetol; 2016 Sep; 15(1):133. PubMed ID: 27619983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
